Linagliptin 5mg Tablet
Reviewed educational reference: what Linagliptin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Linagliptin
- Strength
- 5mg
- Dosage form
- Tablet
- Drug class
- DPP-4 Inhibitor
Related products
No reviewed products are currently published for this generic.
Linagliptin 5mg Tablet is a potent and selective inhibitor of the enzyme dipeptidyl peptidase-4, also known as DPP-4. It is primarily used to manage blood glucose levels in adults with type 2 diabetes mellitus. Unlike many other medications in its class, Linagliptin 5mg Tablet is not primarily cleared by the kidneys, which means it does not require dose adjustments for patients with renal impairment. This unique pharmacokinetic profile makes Linagliptin a highly versatile option for clinicians treating patients with varying degrees of kidney function. It works by enhancing the action of incretin hormones, which help the body produce more insulin when blood sugar is high and stop the liver from releasing too much glucose into the bloodstream.
At a glance
Linagliptin 5mg Tablet is a 5mg tablet containing the active ingredient Linagliptin.
It is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon release.
It is used to control blood sugar in adults with type 2 diabetes mellitus.
Uses of Linagliptin
- Control of blood glucose levels in adults with type 2 diabetes.
- Use as a first line monotherapy when diet and exercise are insufficient.
- Combination therapy with metformin to improve glycemic control.
- Combination therapy with sulfonylureas for patients needing stronger control.
- Management of hyperglycemia in elderly patients where renal safety is a priority.
- Treatment of type 2 diabetes in patients with chronic kidney disease.
Benefits of Linagliptin
Low Risk of Hypoglycemia
When used as a single agent, Linagliptin 5mg Tablet has a very low risk of causing hypoglycemia. This is because its action is glucose dependent, meaning it only stimulates insulin release when blood sugar levels are actually elevated. This provides a significant safety margin compared to insulin or sulfonylureas.
Weight Neutrality
Many diabetes medications cause weight gain, which can worsen the metabolic profile of the patient. Linagliptin is generally weight neutral, meaning it does not cause significant weight gain or loss during treatment, helping patients maintain a healthier body mass index.
Simplified Dosing
Because Linagliptin 5mg Tablet is excreted mainly through the bile and feces, the 5mg dose remains the same regardless of the patient's kidney function. This removes the need for frequent dose recalculations as renal function changes over time.
Side effects of Linagliptin
Most patients tolerate Linagliptin 5mg Tablet well, but some may experience side effects. Common issues include upper respiratory tract infections, nasopharyngitis, and headaches. Some users report joint pain or swelling of the joints. A rare but serious side effect is acute pancreatitis. Patients should be alert for severe, persistent abdominal pain that may radiate to the back. Hypersensitivity reactions are also possible, manifesting as skin rashes, itching, or swelling of the face and throat. In rare cases, heart failure may be exacerbated, characterized by sudden weight gain or shortness of breath. Gastrointestinal upset, such as nausea or diarrhea, occurs infrequently but can happen during the start of therapy.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Nasopharyngitis | Common | Mild | Use over the counter nasal decongestants. |
| Acute Pancreatitis | Rare | Severe | Stop the drug immediately. |
| Hypoglycemia | Uncommon | Moderate | Consume fast acting carbohydrates. |
How to manage side effects
Nasopharyngitis
- Rest
- Hydration
- Symptomatic treatment
Acute Pancreatitis
- Hospitalization
- Fasting
- Intravenous fluids
- Pancreatic enzyme monitoring
Hypoglycemia
- Check blood glucose
- Administer glucose tablets
- Adjust dose of concomitant insulin or sulfonylurea
How to use Linagliptin
- Take one tablet of Linagliptin 5mg Tablet once daily.
- The medication can be taken with or without food.
- Swallow the tablet whole with a glass of water.
- Try to take the dose at the same time every day to maintain a steady level in your body.
- Do not crush, chew, or break the tablet as it may affect how the drug is absorbed.
Special population advice
Kidney impairment
- No dose adjustment is required for any stage of renal failure.
- Safe for use in patients with eGFR below 30 mL/min/1.73m2.
Liver impairment
- No dose adjustment is typically needed for mild to moderate impairment.
- Use with caution in severe hepatic impairment due to biliary excretion.
Children
- Not recommended for patients under 18 years of age.
- Safety and efficacy have not been established in pediatric populations.
Elderly
- Standard 5mg dose is usually well tolerated.
- Monitor for dehydration and potential hypoglycemia if used with other agents.
How Linagliptin works
Linagliptin works by blocking the enzyme DPP-4. This enzyme normally breaks down incretin hormones like GLP-1 and GIP. These hormones are released by the gut after eating and tell the pancreas to release insulin and the liver to stop producing glucose. By inhibiting DPP-4, Linagliptin 5mg Tablet keeps these hormones active for longer. This leads to better insulin secretion and lower glucagon levels, which effectively reduces blood sugar levels after meals and during fasting.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Linagliptin 5mg Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one entirely. Do not take a double dose to make up for a forgotten tablet, as this is not necessary for this medication.
In case of overdose
An overdose of Linagliptin is unlikely to cause severe toxicity on its own. However, if taken with other glucose lowering drugs like insulin, it may increase the risk of hypoglycemia. Symptoms include sweating, tremors, confusion, and rapid heartbeat. Immediate medical attention is required. Treatment focuses on monitoring blood glucose and administering glucose or glucagon if levels drop too low.
Treatment is supportive and focuses on managing blood glucose levels.
- Initial Assessment
- Check blood glucose levels immediately and monitor vital signs.
- Hypoglycemia Management
- Administer oral glucose or intravenous dextrose if blood sugar is critically low.
- Monitoring
- Continuous glucose monitoring until levels stabilize.
- Supportive Care
- Maintain hydration and monitor for any signs of organ dysfunction.
Safety and precautions
When to avoid Linagliptin
- Hypersensitivity
Known allergy to linagliptin or any of the excipients in the tablet.
- Type 1 Diabetes
Not indicated for type 1 diabetes or diabetic ketoacidosis.
- Pancreatitis
Use with extreme caution in patients with a history of pancreatitis.
- Heart Failure
Monitor for signs of worsening heart failure during treatment.
- Severe Hepatic Impairment
Use with caution as the drug is primarily excreted via the biliary route.
- Renal Impairment
Generally safe, but monitor overall renal health as part of diabetes care.
Safety at a glance
Limit alcohol intake as it can cause unpredictable blood sugar levels and increase hypoglycemia risk.
Consult your doctor. There is limited data on use in pregnancy, and insulin is often preferred.
Consult your doctor. It is unknown if Linagliptin passes into breast milk in significant amounts.
This drug does not typically cause sedation or impair your ability to drive.
No dose adjustment is needed for patients with any degree of renal impairment.
Use with care in severe liver disease. Monitor liver function tests periodically.
Do not use if you have a known hypersensitivity to linagliptin or any tablet ingredients.
Safety and efficacy in children under 18 years of age have not been established.
Monitor for dehydration and hypoglycemia, especially in very frail patients.
Interactions
With other medicines
Insulin
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Reduce the dose of insulin when starting Linagliptin 5mg Tablet.
Glibenclamide
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Monitor blood glucose closely and adjust sulfonylurea dose.
Strong CYP3A4 Inducers
MinorChanges how the medicine is processed
What can happen: Potential slight decrease in Linagliptin plasma levels.
What to do: Generally no dose adjustment needed.
With food and drink
- AlcoholModerate
Can cause unpredictable glucose levels and increase hypoglycemia risk when used with other agents.
- Grapefruit JuiceMinor
May theoretically alter minor metabolic pathways, though clinical significance is minimal.
If you have another condition
- Acute Pancreatitis
May exacerbate the condition or be triggered by the drug.
- Congestive Heart Failure
Requires careful monitoring for fluid retention or worsening symptoms.
Effect on laboratory tests
- HbA1c
Decreased
This is the intended therapeutic effect of the drug.
Quick tips
- Monitor your blood glucose levels regularly as directed by your healthcare provider.
- Carry a fast acting source of sugar, such as glucose tablets, if you are using Linagliptin 5mg Tablet with insulin or a sulfonylurea.
- Inform your doctor immediately if you experience severe stomach pain, as this could be a sign of pancreatitis.
- Maintain a balanced diet and a regular exercise routine to help Linagliptin work more effectively.
- Tell your dentist or any surgeon that you are taking this medication before any procedure.
Counselling points
- HypoglycemiaImportant
While Linagliptin 5mg Tablet alone rarely causes low blood sugar, be aware of symptoms like shaking and sweating if you take it with other diabetes drugs.
- Pancreatitis WarningImportant
Tell your doctor immediately if you have severe pain in your upper stomach that spreads to your back.
- ConsistencyGood to know
Take your tablet at the same time every day to keep your blood sugar stable.
- LifestyleGood to know
This medicine works best when you also follow a healthy diet and exercise plan.
Pharmacokinetics
- Absorption
- Rapidly absorbed after oral administration.
- Bioavailability
- Approximately 100 percent.
- Protein binding
- About 98 percent.
- Volume of distribution
- Approximately 110 liters.
- Half-life
- Approximately 7 days.
- Metabolism
- Minimal hepatic metabolism occurs.
- Excretion
- Primarily excreted unchanged in the bile and feces.
- Onset / duration
- Onset of action takes several days, with full effect seen in weeks.
Fact box
- Chemical class
- Xanthine derivative
- Habit forming
- No
- Therapeutic class
- Antidiabetic
- Action class
- Dipeptidyl peptidase-4 inhibitor
- Storage
- Store Linagliptin 5mg Tablet at room temperature, ideally between 15 and 30 degrees Celsius. Keep the tablets in their original blister pack to protect them from moisture and light. Keep out of reach of children.
- ATC code
- A10BH01
- Pregnancy category
- C
More information
Clinical Rationale for Selection
Clinicians often choose Linagliptin 5mg Tablet over other DPP-4 inhibitors when the patient has a history of renal impairment. Most other drugs in this class, such as sitagliptin or vildagliptin, require a dose reduction as the glomerular filtration rate drops. This creates a burden for the physician to constantly monitor creatinine levels and adjust the prescription. Linagliptin eliminates this need. Its primary route of elimination is through the bile and feces, making it a safer and more convenient choice for patients with chronic kidney disease. Additionally, its weight neutral profile makes it attractive for patients who are struggling with obesity and cannot tolerate the weight gain associated with sulfonylureas or insulin.
Comparison with Other Antidiabetics
When compared to Metformin, Linagliptin 5mg Tablet is generally better tolerated with fewer gastrointestinal side effects. However, Metformin remains the first line therapy due to its stronger effect on HbA1c and cardiovascular benefits. Compared to Sulfonylureas, Linagliptin has a significantly lower risk of hypoglycemia and does not cause weight gain. While SGLT2 inhibitors offer better cardiovascular and renal protection, they carry a higher risk of urinary tract infections and genital yeast infections. Linagliptin 5mg Tablet is often used as a second or third agent to add to a regimen when the patient needs more control but cannot tolerate the side effects of other classes or has contraindications to them.
Lifestyle and Dietary Integration
Taking Linagliptin 5mg Tablet is not a substitute for lifestyle modifications. Patients are encouraged to adopt a low glycemic index diet, focusing on complex carbohydrates and high fiber. This helps prevent the sharp spikes in blood glucose that Linagliptin is designed to manage. Regular physical activity, such as brisk walking for 30 minutes a day, improves insulin sensitivity and enhances the drug's efficacy. Patients should be cautioned against excessive alcohol consumption, as alcohol can mask the symptoms of hypoglycemia and interfere with the liver's ability to regulate glucose. Hydration is also key, especially in elderly patients, to prevent acute kidney injury which can complicate diabetes management.
Treatment Expectations and Timeline
Patients should understand that Linagliptin 5mg Tablet does not lower blood sugar instantly like insulin. While some reduction in fasting glucose may be seen within the first week, the primary goal is the reduction of HbA1c. This typically requires 3 to 6 months of consistent therapy. It is common for a doctor to evaluate the patient's progress every few months. If the target HbA1c is not reached, the dose is not increased because the 5mg dose is already the maximum effective dose. Instead, the clinician will likely add another medication, such as Metformin or an SGLT2 inhibitor, to create a synergistic effect. Patients should be encouraged to keep a glucose log to help the doctor make these decisions.
References
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
- Electronic Medicines Compendium. Linagliptin 5 mg tablets, Summary of Product Characteristics.View sourceAccessed
- European Medicines Agency. Trajenta product information.View sourceAccessed
- DailyMed, US National Library of Medicine. Linagliptin label.View sourceAccessed
- Pharmacy Board Kenya. Linvesta 5mg Tablet SmPC.View sourceAccessed
Frequently asked questions about Linagliptin
Can I take Linagliptin 5mg Tablet if I have kidney failure?
Yes, linagliptin is one of the few DPP-4 inhibitors that does not require a dose reduction for kidney impairment because it is mostly excreted through the bile.
Will this medication cause me to gain weight?
No, Linagliptin is generally weight neutral and is unlikely to cause weight gain.
What should I do if I feel severe stomach pain?
Contact your doctor immediately. Severe abdominal pain that goes to the back can be a sign of pancreatitis, a rare but serious side effect.
Can I take this drug on an empty stomach?
Yes, Linagliptin 5mg Tablet can be taken with or without food, as food does not significantly affect its absorption.
How long does it take for Linagliptin 5mg Tablet to start working?
You may see a drop in blood sugar within a few days, but the full effect on your HbA1c levels usually takes 3 to 6 months of consistent use.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →